CDH17 trial for gastric, colorectal and NED cancers using best in class 3rd generation CART is about to kick off. Any one want to guess when Chimeric will announce the first patient dosed for Phase 1?
CDH17 trial for gastric, colorectal and NED cancers using best...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.060M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.4¢ | $27.11K | 6.778M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 40 | 25563938 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 2764371 | 3 |
View Market Depth
| Last trade - 11.20am 20/06/2025 (20 minute delay) ? |
| CHM (ASX) Chart |